Target intelligence / Profile preview

c-myc mRNA

Target
c-myc mRNA
Molecular classification
Other (mRNA transcript)
01

Overview

c-myc mRNA is the messenger RNA that encodes the MYC protein, a transcription factor involved in controlling cell growth, proliferation, differentiation, and apoptosis[7][3][5]. Overexpression or dysregulation of c-myc mRNA leads to increased MYC protein production, promoting uncontrolled cell proliferation and cancer development—most notably observed in Burkitt lymphoma and other aggressive cancers[3][7]. Because direct targeting of the MYC protein remains challenging, c-myc mRNA is being studied as a potential therapeutic target, with strategies including antisense oligonucleotides or small interfering RNAs designed to degrade or block the translation of this mRNA transcript[7]. Elevated c-myc mRNA serves as a potential biomarker for the diagnosis, prognosis, and therapeutic stratification of certain cancers, though any therapy modulating its levels must balance anti-tumor efficacy with the risk of disrupting MYC’s physiological functions in normal tissues[6][7][5].

Other names
MYC mRNAMYC transcriptc-Myc messenger RNA
02

Mechanism of action

Antisense oligonucleotides or RNA interference: Degradation or inhibition of c-myc mRNA, reducing MYC protein synthesis

03

Biological functions

Template for MYC protein synthesisRegulation of cell proliferationRegulation of cell differentiationControl of cell cycleModulation of apoptosis
04

Disease associations

CancerOther (implicated in rapid cell growth and cell cycle disorders)
05

Safety considerations

Off-target effects of RNA-targeted therapiesEssential role of MYC in normal cell function, raising risks of toxicity if MYC expression is excessively suppressed
06

Interacting drugs

(Direct drugs targeting c-myc mRNA are still investigational and not standard therapies; antisense oligonucleotides, siRNAs, and mRNA cleaving strategies are under investigation)
07

Biomarkers

Elevated c-myc mRNA levels (as a marker for MYC-driven tumors or cancer prognosis)

Beyond the preview

Go deeper on c-myc mRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on c-myc mRNA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call